Most Downloaded Articles

Safety and Effectiveness of Tenofovir Alafenamide in the Turkish Population: A Systematic Review
  • Fehmi Tabak
  • Suna Yapalı
  • Mustafa K. Çelen
  • Rahmet Güner
Viral Hepat J 2023; 29: 43-51 DOI: 10.4274/vhd.galenos.2023.2023-8-3
Relationships Between Liver Histopathology with Biochemical Parameters, and Hepatitis B Virus-DNA in Chronic Hepatitis B Infection
  • Yusuf Emre Özdemir
  • Esra Salim Doğdaş
  • Adile Sevde Demir
  • Deniz Borcak
  • Esra Canbolat Ünlü
  • Ayşegül İnci Sezen
  • Osman Faruk Bayramlar
  • Kadriye Kart Yaşar
Viral Hepat J 2023; 29: 75-80 DOI: 10.4274/vhd.galenos.2023.2023-8-2
The Effect of HCV-RNA, HCV-Genotype 1b, and Anti-HCV Positivity on Laboratory Parameters
  • Sanem Karadağ Gencer
  • Yasemin Üstündağ
  • Kağan Huysal
Viral Hepat J 2023; 29: 52-57 DOI: 10.4274/vhd.galenos.2023.2022-11-2
Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Preliminary Findings of Real World Data
  • Tuba Damar Çakırca
  • Tansu Yamazhan
  • Esra Yüksekkaya
  • Fethiye Akgül
  • Behice Kurtaran
  • Ömer Karaşahin
  • Oğuz Karabay
  • Gülten Ünlü
  • İlkay Nur Can
  • Hüsnü Pullukçu
  • Yeşim Taşova
  • Süheyla Kömür
  • Yeşim Yıldız
  • Çiğdem Mermutluoğlu
  • Yakup Demir
  • Mustafa Kemal Çelen
Viral Hepat J 2023; 29: 58-63 DOI: 10.4274/vhd.galenos.2023.2023-5-2
Epidemiology of Viral Hepatitis Changes in Our Country
  • Nurcan BAYKAM
  • Rahmet GÜNER
Viral Hepat J 2018; 24: 1-2 DOI: 10.4274/vhd.2018.1.0001
Eliminating Viral Hepatitis in Turkey: Achievements and Challenges
  • Ulus Salih Akarca
  • Nurcan Baykam
  • Rahmet Güner
  • Fulya Günşar
  • Ramazan İdilman
  • Sabahattin Kaymakoğlu
  • İftihar Köksal
  • Fehmi Tabak
  • Tansu Yamazhan
Viral Hepat J 2022; 28: 47-54 DOI: 10.4274/vhd.galenos.2022.2022-9-1
HBsAg, Anti-HBs, Anti-HCV and Anti-HIV Seroprevalence of the Patients Applied to Artvin State Hospital
  • Ayşe İNCİ
  • Demirhan GÜVEN
  • Murat OKAY
Viral Hepat J 2013; 19: 41-44 DOI: 10.4274/Vhd.03522
Seroprevalence of Hepatitis B Surface Antigen, Anti-Hepatitis B Surface and Anti-Hepatitis C Virus Among Pregnant Women Residing in Şırnak Province
  • Meyha ŞAHİN
  • Meltem ZENCİR
  • Alper Akın GÖZÜBÜYÜK
  • Bedri Aras PEKTAŞ
Viral Hepat J 2018; 24: 7-11 DOI: 10.4274/vhd.0010
The Problem of Access to Hepatitis B Treatment in the Balkan Country of North Macedonia
  • Marija Dimzova
  • Mile Bosilkovski
  • Boban Toshevski
Viral Hepat J 2023; 29: 38-42 DOI: 10.4274/vhd.galenos.2023.2023-4-5
Can We Accurately Assess Fibrosis in Chronic Hepatitis B Virus Patients?
  • Nazlıhan Yalçın
  • Arda Kaya
  • Gamze Şanlıdağ İşbilen
  • Merve Mert Vahabi
  • Hüsnü Pullukçu
  • Tansu Yamazhan
Viral Hepat J 2023; 29: 64-69 DOI: 10.4274/vhd.galenos.2023.2023-6-2
Investigation of Hepatitis B Surface Antibody Levels in Adults with Routine Hepatitis B Vaccination in Childhood
  • Emine Sehmen
  • Esmeray Mutlu Yılmaz
  • Muhammet Ali Oruç
Viral Hepat J 2023; 29: 70-74 DOI: 10.4274/vhd.galenos.2023.2023-4-6
Frequency of Hepatitis Delta Virus in Hepatitis B Surfaceantigen-positive Patients
  • Ayfer Yolcu
  • Nuran Karabulut
  • Sema Alaçam
  • Mustafa Önel
  • Melek Büyük
  • Mine Güllüoğlu
  • Ali Ağaçfidan
Viral Hepat J 2019; 25: 14-18 DOI: 10.4274/vhd.galenos.2018-0018
A Case of Acute Hepatitis B Accompanied by COVID-19 Infection
  • Abdurrahman Kaya
  • Naile Aybike Şahin
  • Adem Tunç
  • Ümit Tozalgan
Viral Hepat J 2023; 29: 87-89 DOI: 10.4274/vhd.galenos.2023.2023-4-4
Post-Treatment Course of Indices Predicting Liver Fibrosis in Adult Chronic Hepatitis C Patients Treated with Direct-Acting Antivirals
  • Ahmet Sertçelik
  • İmran Hasanoğlu
  • Ayşe Kaya Kalem
  • Rahmet Güner
Viral Hepat J 2023; 29: 81-86 DOI: 10.4274/vhd.galenos.2023.2023-8-5
Hepatitis C Prevalence and Responses to Pegylated Interferon + Ribavirin Treatment Among Prisoners
  • Hasan Selçuk ÖZGER
  • Ömer KARAŞAHİN
  • Mehmet Armağan TOY
  • Sibel İBA YILMAZ
  • Kenan HIZEL
Viral Hepat J 2017; 23: 71-75 DOI: 10.4274/vhd.0007
Hepatitis B and C Sero-prevalence in Patients with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome at a Tertiary Care Hospital in Izmir
  • Sabri ATALAY
  • Tuba TATLI KIŞ
  • Ufuk SÖNMEZ
  • Şükran KÖSE
Viral Hepat J 2018; 24: 3-6 DOI: 10.4274/vhd.0005
Relationship Between Basic Laboratory Results and Fibrosis in Chronic Hepatitis B Patients
  • Ertuğrul Güçlü
  • Aziz Öğütlü
  • Mustafa Kösem
  • Ünal Erkorkmaz
  • Oğuz Karabay
Viral Hepat J 2019; 25: 45-49 DOI: 10.4274/vhd.galenos.2019.2019.0010
Occult Hepatitis B in Hemodialysis Patients
  • Pelin Adar
  • Şükran Köse
  • Bengü Tatar
Viral Hepat J 2019; 25: 88-91 DOI: 10.4274/vhd.galenos.2019.2018.0009
Should Hepatitis C Virus Antibody Be Used for Screening Purposes?
  • Birol ŞAFAK
  • Özge TOMBAK
  • Aynur EREN TOPKAYA
Viral Hepat J 2018; 24: 18-20 DOI: 10.4274/vhd.0018
Is Liver Biopsy Necessary in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase Level?
  • İlknur Esen Yıldız
  • İlkay Bahçeci
  • Tuğba Ilgar
  • Mehmet Beyazal
  • Uğur Kostakoğlu
  • Ayşe Ertürk
Viral Hepat J 2022; 28: 1-6 DOI: 10.4274/vhd.galenos.2021.2021-7-1
Seroprevalence of Hepatitis A and Hepatitis E in Adults Patient Admitted Izmir Katip Çelebi University Atatürk Training and Research Hospital
  • Berrin KARAAYAK UZUN
  • Hüseyin Hakan ER
  • Serdar GÜNGÖR
  • Bayram PEKTAŞ
  • Nurten BARAN
  • Süreyya GÜL YURTSEVER
  • Tuna DEMİRDAL
Viral Hepat J 2013; 19: 76-79 DOI: 10.4274/Vhd.99608
What is the Current Situation of HBV, HCV and HIV Seroprevalence Among Syrian Refugees? Patients Evaluated Preoperatively Over Ten Years
  • Mehmet Selim Çömez
  • Tayibe Bal
  • Mehmet Çabalak
Viral Hepat J 2022; 28: 55-60 DOI: 10.4274/vhd.galenos.2022.2021-9-1
The Change in Epidemiological Pattern of Hepatitis Delta Virus İnfection and the Current Stiuation in our Country
  • Selma TOSUN
Viral Hepat J 2013; 19: 1-7 DOI: 10.4274/Vhd.77487
Hepatitis B Virus: Biology and Life Cycle
  • Neşe İnan
  • Fehmi Tabak
Viral Hepat J 2015; 21: 1-7 DOI: 10.4274/vhd.36036
Assessment of Quality of Life of Patients with Chronic Hepatitis B and C Treated with Pegylated Interferon-alpha
  • Handan ALAY
  • Kemalettin ÖZDEN
  • Serpil EROL
  • Neslihan ÇELİK
  • Emine PARLAK
  • Mehmet PARLAK
Viral Hepat J 2018; 24: 25-42 DOI: 10.4274/vhd.2017.0016
Hepatitis B Virus Infection: Knowledge and Awareness Among the Patients Admitted in a Tertiary Care Hospital in Bangladesh
  • Nahida Zafrin
  • M.A. Sattar Sarkar
  • Md. Motlabur Rahman
  • Umma Salma
  • Tania Mahbub
  • Muhammed Abu Azhar
Viral Hepat J 2019; 25: 6-13 DOI: 10.4274/vhd.galenos.2018.0016
Sixteen-year Prognosis of Treatment-naive Patients with Hepatitis C Infection
  • Zehra Karacaer
  • Selma Tosun
  • Ayşe Batirel
  • Ali Acar
  • Neslihan Çelik
  • Mustafa Uğuz
  • Songül Yavuz
  • Ercan Yenilmez
  • Mustafa Doğan
  • Tuğba Yanık Yalçın
  • Büşra Ergut Sezer
  • Nefise Öztoprak
  • Özlem Aydın
  • İlknur Esen Yıldız
  • Uğur Kostakoğlu
  • Pınar Ergen
  • Rıza Aytaç Çetinkaya
  • Gül Durmuş
  • Ramazan Gözüküçük
  • Seher Ayten Coşkuner
  • Cumhur Artuk
  • Emine Fırat Göktaş
  • Emre Güven
  • Muhammed Bekçibaşı
Viral Hepat J 2019; 25: 19-24 DOI: 10.4274/vhd.galenos.2018.0026
Demographic Characteristics and Transmission Risk Factors of Patients with Hepatitis C Virus in Turkey: The EPI-C, A Multicenter and Cross-sectional Trial
  • Fehmi Tabak
  • Göktuğ Şirin
  • Mehmet Demir
  • Murat Aladağ
  • Şua Sümer
  • Behice Kurtaran
  • Selma Tosun
  • Tansu Yamazhan
  • İlkay Bozkurt
  • Yunus Gürbüz
  • Ayşe Batırel
  • Ebubekir Şenateş
  • Fatma Özlem Kandemir
  • Firdevs Topal
  • Hamdi Levent Doğanay
  • Orhan Sezgin
  • Reşit Mıstık
  • Şükran Köse
  • Yusuf Yılmaz
  • Dilara İnan
  • İftihar Köksal
  • Emine Parlak
  • Meral Akdoğan
  • Rahmet Güner
Viral Hepat J 2021; 27: 109-117 DOI: 10.4274/vhd.galenos.2021.2021-1-3
HBsAg, Anti-HBs, Anti-HCV and HIV Seroprevalence in Hemodialysis Patients in Elazığ Province
  • Gülden ESER KARLIDAĞ
  • Mehmet KÜÇÜKSU
  • Mustafa DEMİR
Viral Hepat J 2018; 24: 53-56 DOI: 10.4274/vhd.2018.0004
A Misleading Parameter in the Diagnosis of Chronic Hepatitis B: Persistently Normal Transaminases
  • Osman ÖZDOĞAN
  • Serkan YARAŞ
  • Ali Riza KÖKSAL
  • Engin ALTINKAYA
  • Mehmet BAYRAM
  • Banu YILMAZ ÖZGÜVEN
  • Canan ALKIM
Viral Hepat J 2018; 24: 79-84 DOI: 10.4274/vhd.2018.0010
Evaluation of Health-Related Life Quality of Patients with Chronic Hepatitis Admitted to a Medical Faculty Hospital
  • Belgin Oral
  • İskender Gün
  • Fevziye Çetinkaya
Viral Hepat J 2020; 26: 151-157 DOI: 10.4274/vhd.galenos.2020.2020.0011
Comparison of Liver Histopathology with Non-invasive Inflammation Markers as Neutrophil-lymphocyte Ratio, Platelet-lymphocyte Ratio and Mean Platelet Volume in Chronic Hepatitis B Patients
  • Hakan Demiröz
  • Mehmet Bayram
  • Kader Irak
  • Özgür Yıldırım
  • Abdulbaki Kumbasar
  • Ömür Tabak
Viral Hepat J 2021; 27: 1-5 DOI: 10.4274/vhd.galenos.2021.2020-11-3
Hepatitis C Genotype Distribution Changing Through Years in the Kahramanmaraş Region
  • Kadir Gişi
  • Murat İspiroğlu
  • Ahmet Rıza Şahin
  • Murat Aral
  • Bülent Kantarçeken
Viral Hepat J 2022; 28: 67-71 DOI: 10.4274/vhd.galenos.2022.2021-2-3
Anti-HAV IgG Prevalence of Health Care Workers and Students
  • Serkan ÖNCÜ
  • Barçin ÖZTÜRK
  • Müjgan AYDEMIR
  • Selcen ÖNCÜ
  • Serhan SAKARYA
Viral Hepat J 2004; 9: 162-165
Investigation of Mean Platelet Volume, Platelet Distribution Width and Erythrocyte Distribution Width in Patients with Hepatitis B Virus Infection
  • Kazım KIRATLI
  • Erdem ÇEVİK
Viral Hepat J 2017; 23: 60-63 DOI: 10.4274/vhd.62534
Percutaneous Liver Needle Biopsy Methods Can Be Safe and Effective in Patients with Viral Hepatitis
  • Zehra KARACAER
  • Fatma YILMAZ KARADAĞ
  • Gül DURMUŞ
  • Hüseyin ÇİÇEK
  • Emine PARLAK
  • Alpay ARI
  • Selma TOSUN
  • Yavuz DURMUŞ
  • Suat EREN
  • Zehra ADIBELLİ
Viral Hepat J 2017; 23: 65-70 DOI: 10.4274/vhd.0001
Epidemiology of Hepatitis C in North Cyprus
  • Meryem GÜVENİR
  • Kaya SÜER
Viral Hepat J 2018; 24: 21-23 DOI: 10.4274/vhd.0006
The Importance of Antiviral Prophylaxis against Hepatitis B Virus in Patients under Immunosuppressive Therapy
  • Firdevs Aksoy
  • Selçuk Kaya
  • Hanife Nur Karakoç
  • Gürdal Yılmaz
  • Serhat Atalar
  • İftihar Köksal
Viral Hepat J 2019; 25: 50-54 DOI: 10.4274/vhd.galenos.2019.2018.0027
Relationship between Viral Load and Hepatic Histopathology in Patients with Chronic Hepatitis B
  • Damla Akdağ
  • Tansu Yamazhan
  • Hüsnü Pullukçu
  • Meltem Işıkgöz Taşbakan
  • Raika Durusoy
Viral Hepat J 2020; 26: 1-4 DOI: 10.4274/vhd.galenos.2019.2019.0040
Seroprevalence Investigation of Hepatitis B and Hepatitis B Core Antigen in Oncology Patients
  • İrem Akdemir Kalkan
  • Ayşe Demirci
  • Güle Çınar
  • Mustafa Kemal Çelen
Viral Hepat J 2020; 26: 110-113 DOI: 10.4274/vhd.galenos.2020.2019.0036
Effect of Hepatitis B Virus Genotypes and Viral Load on the Response of Patients Treated with Peginterferon-α-2a
  • Majid Mahmood
  • Muhammad Asim Anwar
  • Muhammad Naseem Hasrat
  • Zahid Azam
Viral Hepat J 2021; 27: 131-135 DOI: 10.4274/vhd.galenos.2021.2021-5-6
Is There an Association Between Hepatitis B and Atherosclerosis?
  • Zuhal Çalışkan
  • Özge Telci Caklılı
Viral Hepat J 2019; 25: 35-39 DOI: 10.4274/vhd.galenos.2019.2019.0009
Evaluation of HCV-Core Antigen in Diagnosis of Chronic Hepatitis C Patients under Direct-Acting Antiviral Treatment
  • Müge Toygar Deniz
  • Sıla Akhan
  • Murat Sayan
  • Gülden Sönmez Tamer
  • Emel Azak
Viral Hepat J 2022; 28: 25-31 DOI: 10.4274/vhd.galenos.2022.2021-3-2
The Seroprevalence of Hepatitis A Virus in Patients with Chronic Hepatitis
  • Hayat KUMBASAR KARAOSMANOGLU
  • Fehmi TABAK
  • Resat ÖZARAS
  • Bekir KOCAZEYBEK
  • Ali MERT
  • Hakan SENTÜRK
Viral Hepat J 2004; 9: 152-155
Chronic Hepatitis C Prevalence and Physician Awareness in Southeastern Turkey
  • Nurettin Tunç
Viral Hepat J 2019; 25: 101-104 DOI: 10.4274/vhd.galenos.2019.2019.0031
The Treatment of Ledipasvir/Sofosbuvir in Patients with Chronic Hepatitis C Virus: The Results of Five-year Follow-up
  • Murat Pekgöz
  • Nevin İnce
Viral Hepat J 2021; 27: 124-130 DOI: 10.4274/vhd.galenos.2021.2021-6-1
The Direct Medical Cost of Regular Monitoring of Patients with HBeAg-Negative Chronic Hepatitis B Virus Infection
  • Ahmet Naci Emecen
  • Hülya Çaşkurlu
  • Pınar Ergen
  • Yasemin Çağ
  • Ferhat Arslan
  • Haluk Vahaboğlu
Viral Hepat J 2022; 28: 61-66 DOI: 10.4274/vhd.galenos.2022.2021-12-1
Comparison of HBsAg and HBeAg Levels with HBV DNA and ALT Levels in Patients with Chronic Hepatitis B Infections
  • İmran SAĞLIK
  • Derya MUTLU
  • Gözde ÖNGÜT
  • Halide AKBAŞ
  • Hülya İren GÜVENÇ
  • Dilara ÖĞÜNÇ
  • Dilek ÇOLAK
Viral Hepat J 2013; 19: 119-122 DOI: 10.4274/Vhd.84856
Distribution of Hepatitis C Virus Genotypes in Aydın Province
  • Yasin TİRYAKİ
  • Alev ÇETİN DURAN
  • Osman Olcay ÖZÇOLPAN
Viral Hepat J 2018; 24: 70-74 DOI: 10.4274/vhd.2018.0019
A Comparison of Needle Types and Biopsy Techniques Used in Liver Biopsies of Chronic Hepatitis B Patients
  • Erdal Karavaş
  • Faruk Karakeçili
  • Mecdi Gürhan Balcı
Viral Hepat J 2019; 25: 1-5 DOI: 10.4274/vhd.galenos.2018.0030